Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%

Stock Information for Xtant Medical Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Xtant Medical Holdings Inc.

Xtant Medical Announces Commercial Launch of its Next-Generation nanOss Strata(TM) Synthetic Bone Graft
Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine
Xtant Medical Reports Third Quarter 2025 Financial Results
Xtant Medical Announces Commercial Launch of CollagenX(TM)
Xtant Medical to Announce Third Quarter 2025 Financial Results on November 11, 2025
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Xtant Medical Reports Second Quarter 2025 Financial Results
Xtant Medical to Attend the CG 45th Annual Growth Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.